• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2025, Vol. 27 ›› Issue (6): 835-841.DOI: 10.3969/j.issn.1671-2587.2025.06.014

Previous Articles     Next Articles

A Case Analysis of Autoimmune Hemolytic Anemia and Delayed Hemolytic Transfusion Reaction after Umbilical Cord Blood Transplantation

MA Ting1, FAN Liangfeng2, LI Jingwei3, SUN Yang1, YANG Jiangcun1, XIANG Dong2   

  1. 1Department of Transfusion Medicine, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi 710068;
    2Shanghai Blood Center, Shanghai 200000;
    3Department of Transfusion Medicine, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072
  • Received:2024-12-11 Published:2025-12-24

Abstract: Objective To investigate the rational application of serological techniques in ensuring safe transfusion for a patient with autoimmune hemolytic anemia (AIHA) following umbilical cord blood transplantation in cases of incompatibility crossmatch. Methods A series of tests, including direct antiglobulin test (DAT), antibody identification test, absorption test, acid elution test, antibody titer measurement, and microcolumn agglutination cross-matching test, were performed on the patient's blood samples. Results The patient's blood type was identified as type B and Lua antigen was negativity. A Hemolytic crisis occurred after multiple transfusions of red blood cells. IgG-type anti-Ec and anti-Lua antibodies were detected in both serum and exudate samples. Tests showed a delayed hemolytic transfusion reaction (DHTR) caused by anti-Ec. Following compatible red blood cells transfusions, the patient's hemoglobin levels showed a significantly improvement, and flow cytometry results indicated a gradual decrease in the proportion of antigen-sensitized cells in the patient's blood. Conclusion DHTR induced by anti-Ec can exacerbate anemia in AIHA patients and may pose a significant risk of hemolysis. The appropriate selection and application of serological techniques can facilitate the identification of clinically significant antibodies, which is crucial for ensuring the transfusion safety.

Key words: Umbilical cord blood transplantation, Anti-Ec, Anti-Lua, Delayed hemolytic transfusion reaction Autoimmune hemolytic anemia

CLC Number: